Global Inflammatory Bowel Disease (IBD) Diagnostic Market Share

Statistics for the 2023 & 2024 Global Inflammatory Bowel Disease (IBD) Diagnostic market share, created by Mordor Intelligence™ Industry Reports. Global Inflammatory Bowel Disease (IBD) Diagnostic share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Medical Devices Research Diagnostic Devices Research Clinical Diagnostic Devices Research Clinical Diagnostic Laboratory Equipment Research Disease Specific Diagnostic Devices Research Gastroenterology Diagnostics Research Global Inflammatory Bowel Disease (IBD) Diagnostic Market Market Share

Market Share of Global Inflammatory Bowel Disease (IBD) Diagnostic Industry

The Inflammatory Bowel Disease (IBD) diagnostics market is fragmented and competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market DiaSorin S.p.A, Quidel Corporation, and American Laboratory Products Company (ALPCO), Certest Biotec SL, and others.

Inflammatory Bowel Disease Diagnostic Market Leaders

  1. DiaSorin S.p.A

  2. BUHLMANN Laboratories AG

  3. Quidel Corporation

  4. Certest Biotec SL.

  5. American Laboratory Products Company (ALPCO)

*Disclaimer: Major Players sorted in no particular order

IBD Diagnostic Market Concentration

Global Inflammatory Bowel Disease (IBD) Diagnostic Market Report Snapshots

Inflammatory Bowel Disease (IBD) Diagnostic Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)